
(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults up to 49 years old … Read the full press release
(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults up to 49 years old … Read the full press release
(IN BRIEF) GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses against influenza A and B strains in both younger and older adults. The trial met success criteria … Read the full press release
Posted in Business, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged flu vaccine, GSK, mRNA, Phase II, Phase III, safety, Tony Wood
(IN BRIEF) AstraZeneca’s Supplemental Biologics License Application (sBLA) seeking approval for a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray flu vaccine, has been accepted for review by the US Food and Drug Administration (FDA). If approved, … Read the full press release
(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original ‘red brick’ civic universities, has announced that its researchers are part of a new project to increase the number of care home staff that take … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Boots UK, Care England, care home staff, care homes, Day Lewis Pharmacy, Dr Alys Griffiths, Dr Amrish Patel, flu, flu vaccine, FluCare project, Liz Jones, National Care Forum, National Institute for Health Research, NIHR, pharmacists, Public Health England, researchers, UEA, University of East Anglia, University of Leicester, University of Liverpool, vaccine